Xvivo Perfusion AB announced following members have been appointed to nomination committee for the 2023 annual general meeting: Henrik Blomquist, appointed by Bure Equity AB, Caroline Sjösten appointed by Swedbank Robur Fonder AB, Thomas Ehlin, appointed by The Fourth Swedish National Pension Fund and Gösta Johannesson, chairman of the board of directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
392 SEK | -1.01% | +2.62% | +18.97% |
Apr. 24 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
Apr. 24 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.97% | 1.17B | |
-5.45% | 182B | |
+3.53% | 114B | |
-3.22% | 68.38B | |
+6.07% | 52.46B | |
+7.95% | 44.25B | |
+7.52% | 43.55B | |
+25.10% | 32.69B | |
+17.85% | 26.73B | |
-0.37% | 25.79B |
- Stock Market
- Equities
- XVIVO Stock
- News Xvivo Perfusion AB
- Xvivo Perfusion AB Announces Nomination Committee for the 2023 Annual General Meeting